AP Syllabus focus:
‘Biological treatments include psychoactive medications, which can produce side effects such as tardive dyskinesia, and invasive procedures such as TMS, electroconvulsive therapy, and rare psychosurgery.’
Biological interventions treat psychological disorders by directly changing brain chemistry or neural activity. In AP Psychology, focus on psychoactive medications, their side effects (including tardive dyskinesia), and major invasive procedures: TMS, electroconvulsive therapy, and rare psychosurgery.
What Counts as a Biological Intervention?
Biological interventions are treatments that target biological mechanisms (e.g., neurotransmitters, brain circuits) to reduce symptoms and improve functioning. They are often used alongside psychotherapy and require careful monitoring for benefits and risks.
Psychoactive (Psychotropic) Medications
Medication aims to alter neurotransmission (such as dopamine, serotonin, or norepinephrine) to change mood, thinking, or behavior.
Psychoactive (psychotropic) medication: A drug that affects the central nervous system and changes perceptions, mood, cognition, or behavior to reduce symptoms of a psychological disorder.
Common medication goals (high-utility patterns)
Reduce symptom intensity (e.g., panic frequency, manic activation, psychotic experiences)
Prevent relapse by maintaining more stable brain activity over time
Improve daily functioning, not just eliminate all symptoms
Key trade-offs in medication treatment
Speed vs. durability: medications may reduce symptoms relatively quickly, but stopping can lead to symptom return.
Effectiveness vs. side effects: beneficial symptom change may come with physical or psychological costs.
Adherence challenges: side effects, stigma, or feeling “numb” can reduce consistent use.
Side effects and risks (including tardive dyskinesia)
Side effects range from mild (sleep changes) to severe (movement disorders). One especially important AP term is tardive dyskinesia, classically associated with long-term use of some antipsychotic medications.
Tardive dyskinesia: A potentially irreversible movement disorder involving involuntary, repetitive movements (often facial tics or tongue movements), associated with prolonged use of certain antipsychotic drugs.
Risk management typically includes:
Using the lowest effective dose
Regularly assessing motor symptoms and overall functioning
Adjusting medication when risks outweigh benefits
Invasive Procedures and Brain Stimulation
When symptoms are severe, resistant to standard treatments, or urgently dangerous, clinicians may consider procedures that directly stimulate or alter brain function. These are typically more regulated and used less often than medication.
Transcranial Magnetic Stimulation (TMS)
TMS uses magnetic fields to influence neural firing in targeted brain regions (often cortical areas implicated in mood regulation).
Diagram of transcranial magnetic stimulation (TMS) illustrating a figure‑8 coil on the scalp and the magnetic field lines that induce electrical activity in the underlying cortex. The visual emphasizes why TMS is considered noninvasive: the stimulation is delivered through the skull without surgery while still targeting specific brain regions. Source
It is typically administered in repeated sessions.
Transcranial magnetic stimulation (TMS): A noninvasive procedure that uses focused magnetic pulses to stimulate or modulate activity in specific brain areas to reduce symptoms (commonly in mood disorders).
Core AP-relevant features:
Noninvasive (no surgery; stimulation occurs through the skull)
Targets brain circuits rather than whole-brain sedation
Often considered when medication has not produced sufficient improvement
Electroconvulsive Therapy (ECT)
Electroconvulsive therapy involves inducing a controlled seizure under anesthesia.
Medical illustration of electroconvulsive therapy (ECT) showing electrode placement on the scalp and the concept of electrically induced seizure activity. It helps connect the procedure steps to the key idea that ECT uses controlled electrical stimulation (under anesthesia and monitoring) to produce therapeutic changes in brain function. Source
Despite historical stigma, modern ECT is a medical procedure with monitoring and is used when rapid symptom reduction is critical.
Electroconvulsive therapy (ECT): A biomedical treatment in which a controlled seizure is induced under anesthesia to produce therapeutic changes in brain activity, often used for severe or treatment-resistant conditions.
Important considerations:
Potential benefits include rapid symptom relief in severe cases
Risks can include confusion and memory problems (often short-term but clinically significant)
Rare Psychosurgery
Psychosurgery refers to surgical alteration of brain tissue to reduce severe, chronic symptoms that have not responded to other treatments. It is rare due to ethical concerns, irreversibility, and the availability of less invasive options.
Psychosurgery: A rare, irreversible surgical procedure that destroys or alters specific brain tissue to alleviate severe psychological symptoms when other treatments have failed.
Key AP framing:
Considered only after extensive evaluation and failed alternatives
Raises heightened ethical issues because effects can be permanent
Safety, Ethics, and Decision-Making
Choosing a biological intervention typically weighs:
Severity and urgency of symptoms (e.g., immediate risk)
Past treatment response (treatment-resistant patterns)
Side effect burden and long-term risks (including tardive dyskinesia)
Informed consent and ongoing monitoring of outcomes
FAQ
Targeting is based on research linking particular cortical networks to symptoms and on clinical protocols.
Some services use MRI-guided or measurement-based approaches to improve precision, but protocols vary by clinic and country.
One explanation is long-term changes in dopamine-related pathways after extended receptor blockade.
Persistence risk appears higher with longer exposure and higher cumulative dose, which is why regular screening and early detection are emphasised.
Modern ECT is performed with anaesthesia and muscle relaxants, with monitoring of vital signs and seizure duration.
Treatment parameters (dose, electrode placement, frequency) are adjusted to balance benefit and cognitive side effects.
Some patients receive “maintenance” or “booster” sessions to reduce relapse risk.
Clinicians may also adjust medications and follow-up schedules to maintain gains, depending on symptom return patterns.
Common safeguards include independent specialist review, documentation that multiple evidence-based treatments have failed, and robust informed consent procedures.
Additional protections may involve ethics committees, legal oversight, and detailed follow-up plans due to irreversibility.
Practice Questions
Outline one possible side effect of psychoactive medication and briefly state why it is significant for treatment decisions. (2 marks)
1 mark: Identifies an appropriate side effect (e.g., tardive dyskinesia).
1 mark: Explains significance (e.g., can be severe/long-lasting, affects adherence, requires monitoring and risk–benefit evaluation).
Compare TMS, electroconvulsive therapy (ECT), and psychosurgery as biological interventions. In your answer, include one similarity and two differences, and refer to why psychosurgery is rare. (6 marks)
1 mark: Correct similarity (all are biological interventions that aim to change brain activity to reduce symptoms).
1 mark: Correct difference between TMS and ECT (TMS uses magnetic stimulation; ECT induces a controlled seizure under anaesthesia).
1 mark: Correct difference involving invasiveness/irreversibility (psychosurgery is surgical and irreversible; TMS/ECT are not surgical brain lesion procedures).
1 mark: Notes TMS is noninvasive (through skull; no surgery).
1 mark: Notes ECT is used for severe cases and can have memory/confusion side effects.
1 mark: Explains psychosurgery is rare due to ethical concerns, irreversibility, and being reserved for treatment-resistant cases.
